Clinical Oncology Week articles from October 2003

Clinical Oncology Week archives from October 2003

Link found to developmental cell signaling pathway.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Scientists at University of California San Francisco (UCSF) and Massachusetts General Hospital (MGH) have found strong evidence that a cell signaling pathway active in embryonic development plays a...

Low-molecular-weight heparins are safe and effective for cancer patients.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Low-molecular-weight heparins are safe and effective in cancer patients According to a study from Canada, "Accumulating evidence suggests that low-molecular-weight heparins are the drug of choice...

Docetaxel and capecitabine improve survival in metastatic breast cancer.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Docetaxel and capecitabine improve survival in metastatic breast cancer. "Docetaxel (Taxotere) and capecitabine (Xeloda) demonstrate synergy in preclinical studies and both show high single-agent...

Zoledronic acid is effective in managing metastatic bone disease.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Zoledronic acid is effective in managing metastatic bone disease According to published research from Scotland, "Many advanced cancers, particularly breast cancer and prostate cancer, metastasize to...

Doctor's urging may boost screening for those at risk.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Encouragement from family physicians could persuade more relatives of colorectal cancer patients to take a life-saving screening test for the disease, according to a new study. More than 143,000...

Phase II study demonstrates vaccine effectiveness in half of patients.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- A Phase II clinical study reports that administration of a prototype vaccine, developed by Therion Biologics Corp., administered in combination with interleukin-2 (IL-2), generated objective tumor...

Folkman honored for hypertension research.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Judah Folkman, MD, is the winner of this year's Novartis Award for Hypertension Research. He is a pioneer in the field of angiogenesis. His work has led to a better understanding of how angiogenesis is...

Prior lymphoplasmacytic lymphoma is linked to diffuse large B-cell lymphoma.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia have a risk of developing diffuse large B cell lymphoma at the same time as, or following, the initial disease. According to a...

Researchers identify cancer stem cell for brain tumors.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- A research team at the Hospital for Sick Children (HSC) and the University of Toronto (U of T), led by Dr. Peter Dirks, has identified for the first time a cancer stem cell in both malignant and benign...

Population pharmacokinetics of low-dose paclitaxel evaluated in brain tumors.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Population pharmacokinetics of low-dose paclitaxel was evaluated in patients with brain tumors. According to a study from Germany, "Our aim was to assess the pharmacokinetics of a low-dose schedule...

Survivin, an apoptosis inhibitor, is widely expressed in brain tumors.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Survivin, an apoptosis inhibitor, is widely expressed by brain tumors and may be a good immunotherapeutic target. According to published research from Switzerland, "Survivin, a member of the...

Breast cancer mortality in the Netherlands has been decreasing since 1997.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Breast cancer mortality in The Netherlands has been decreasing since 1997. "The Netherlands breast cancer screening program for women aged 50 - 75 years was gradually implemented during 1989 -...

Can healthy bones help prevent metastasis?
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Bones are the most common place in the body where breast cancer spreads, or metastasizes. Physicians at Fox Chase Cancer Center, Philadelphia, Pennsylvania, are studying the drug clodronate to see if it...

Exemestane demonstrates clinical benefit in advanced disease.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Results of a Phase II clinical trial indicate that the aromatase inhibitor exemestane demonstrates a high response rate for first-line treatment of advanced breast cancer in postmenopausal women. ...

Patients offer recommendations for care to their physicians.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Patients with breast cancer offer recommendations for care to their physicians. "Women enter an increasingly complex medical system when they receive the diagnosis of breast cancer. Subsequently,...

Patients treated by low-workload surgeons had poorer survival.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Patients treated by low-workload surgeons had poorer survival. "The formation of multidisciplinary breast teams across the UK is intended to concentrate the assessment and treatment of breast cancer...

Some types of tumors behave in an unexpected way.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Tumor size may not be an accurate method of predicting lymph node involvement and disease progression in some breast cancers, according to investigators at the Research Institute of the McGill...

Study tests examestane for use after 5 years of preventive tamoxifen.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Doctors recommend that many postmenopausal women with breast cancer take tamoxifen for 5 years after treatment to prevent recurrence of their cancer. There is no standard therapy given after 5 years of...

Ultrasound may be an adjunct to mammography in diagnosing breast masses.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Ultrasound may be an adjunct to mammography in diagnosing breast masses. According to recent research published in the journal Physics in Medicine and Biology, "Classification of breast masses in...

Zoledronic acid is the preferred therapy for treatment of bone metastases.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Zoledronic acid is the preferred therapy for treatment of bone metastases. According to published research from Belgium, "Various primary malignancies develop bone metastases, and the resultant...

Longer commute for cancer treatment associated with better survival.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Cancer patients who travel more than 15 miles for treatment appear to survive longer than patients who live closer to their treatment center, even after controlling for factors such as disease stage and...

Genetic differences revealed by SNPS play a role in risk, prevention, outcomes.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Roughly 99.9% of your genetic makeup is identical to every other human being, which makes the remaining tenth of a percent all the more interesting. Scientists around the world are feverishly...

Method to keep track of comorbidities is successful.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Many cancer patients have other diseases, and those ailments can influence their chance of survival and response to treatment. Although physicians take a person's overall health into account when...

Certain enzyme inhibitors show promise.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Certain enzyme inhibitors may slow tumor formation within weeks and could lead to treatments that retard or prevent recurrences of cancers, researchers at University of Texas Southwestern Medical Center...

Sphingosine kinase inhibitors may hold key to halting growth of some tumors.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Penn State College of Medicine researchers have identified compounds that could wipe out an enzyme responsible for tumor growth. "These compounds our team found are the first 'drug-like' agents...

Starve a tumor or feed a tumor?
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Within a tumor, chaos reigns: Nutrients are scarce, and healthy tissue is muscled out by cancerous tissue so aggressive that the tumor even sacrifices parts of itself to continue its relentless...

Fatigue is common complaint of patients with cancer.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- A new review finds clinicians rarely discuss fatigue with their patients, even though it has a significant impact on quality of life and effective treatments are available. The literature review of...

Researchers design a novel applicator for low-dose-rate brachytherapy.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Researchers design a novel applicator for low-dose-rate brachytherapy. According to recent research published in the International Journal of Gynecological Cancer, "The standard low-dose-rate (LDR)...

Study shows overweight, obesity linked to increased cancer risk.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- A new study by researchers at the U.S. National Cancer Institute (NCI) suggests being overweight could double a woman's risk of developing one type of cervical cancer, known as cervical adenocarcinoma....

Engineered antibodies may expedite development of therapeutic oncology agents.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Panacea Pharmaceuticals, Inc., has extended and expanded its collaborative research agreement with researchers at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, covering...

Microsphere design holds promise for the colonic delivery of 5-fluorouracil.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Microsphere design holds promise for the colonic delivery of 5-fluorouracil. "The treatment of colon cancer has been aimed by approaches of oral drug administration. 5-Fluorouracil is the standard...

Poloxamer-containing liposomes can be used for heat-sensitive drug delivery.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Poloxamer-containing liposomes as a heat-sensitive drug delivery system in vivo for colon tumors. According to published research from the United States, "A heat-sensitive liposomal drug delivery...

A medical nutriment has supportive value in the treatment of colorectal cancer.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- A medical nutriment has supportive value in the treatment of colorectal cancer. "MSC (Avemar) is a medical nutriment of which preclinical and observational clinical studies suggested an...

Ubiquitin-like peptide with anticancer and immunostimulatory activity isolated from mushroom.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- A novel peptide with anticancer and immunostimulatory activity has been extracted from a common mushroom. In a recent study from China, "A peptide, with a molecular mass of 9.5 kDa and...

Osseous FDG uptake is normal 3 months after traumatic or surgical fractures.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Osseous FDG uptake is normal 3 months after traumatic or surgical fractures. "It is known that following a traumatic fracture or surgical intervention, bone scintigraphy reveals positive results for...

Clinical findings, treatment, outcome of endometriosis-related malignancies reviewed.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Clinical findings, treatment, and outcome of endometriosis-related malignancies are reviewed. "The purpose of this study is to describe the clinical findings, treatment, and outcome of patients...

Faster radiotherapy more effective.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- The world's largest trial in accelerated radiotherapy for head and neck cancer - the DAHANCA trial - proves conclusively that increasing the number of treatments per week from five to six can benefit...

Sentinel lymph node biopsy in head and neck cancer is experimental.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Sentinel lymph node biopsy in head and neck cancer is experimental. "In the past decade. the technique of sentinel lymph node biopsy (SLNB) has been applied to a vast array of primary neoplasms,...

[F-18]FDG PET with hybrid PET scanners is diagnostically superior to CT and MRI.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- [F-18]FDG PET with hybrid PET scanners is diagnostically superior to CT and MRI. According to a study from Germany, "The aim of this study was to evaluate fluorine-18 fluorodeoxyglucose ([F-18]FDG)...

Routine CT scan is of little value in following patients with Hodgkin's disease.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Routine CT scan is of little value in following patients with Hodgkin disease. "A total of 10-40% of patients with Hodgkin's disease relapse following initial curative therapy. Intensive follow-up...

Data lacking on venous thromboembolism prophylaxis.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Data are lacking regarding prophylaxis against venous thromboembolism. "Currently there are limited randomized data regarding thromboprophylaxis in laparoscopic surgery. The aim of this article is...

High-dose hydroxyurea shows promise for treatment of high-risk AML patients.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- High-dose hydroxyurea (HHY) shows promise for the treatment of high-risk AML patients. Researchers in Italy conducted a study "to evaluate the antileukemic effectiveness and toxicity" of HHY and "to...

Laser therapy offers alternative to surgery for liver tumors.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Laser light can be delivered in a controlled and predictable manner to destroy tumors. By inserting fiber optic cables through needles, doctors can direct the powerful laser light onto liver tumors -...

Combined CPT-11 and ifosfamide is effective in relapsed SCLC.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Combined CPT-11 and ifosfamide is effective in relapsed SCLC. "This phase II study was conducted to investigate the efficacy and safety of irinotecan (CPT-11) and ifosfamide as second-line...

New blood test could detect disease in its earliest stages.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Lung cancer is often deadly by the time doctors have detected it, but scientists at Duke University Medical Center are developing a noninvasive test that could detect lung cancer in its earliest stages,...

Tc-99m-MIBI scintigraphy might be valuable in detecting recurrent lung cancer.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Tc-99m-MIBI scintigraphy might be valuable in detecting recurrent lung cancer. "After radiation therapy of lung cancer, a dense fibrotic shadow develops in the irradiated lung. Owing to this...

Ultrasound-guided endoscopy may have role in evaluation of mediastinal lesions.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Ultrasound-guided endoscopy may have role in the evaluation of mediastinal lung cancer lesions. "The evaluation of the mediastinum is still a challenge. In most cases, a pathologic study is...

Vitamin K2 may be used for lung cancer therapy.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Vitamin K2 may be used for lung cancer therapy. According to published research from Japan, "Vitamin K2 (menaquinone-4: VK2) has been reported to show apoptosis and differentiation-inducing effects...

Researchers find genetic variations may predict treatment responses.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Researchers from the Cancer Center at the University of Minnesota have demonstrated that variations in genes may determine the outcome and toxicity of treatments for myeloma cancer patients. The...

Medicare coding instructions issued for Bexxar.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Corixa Corp. (NASDAQ:CRXA) and GlaxoSmithKline (NYSE:GSK) announced that the Center for Medicare & Medicaid Services (CMS) has issued coding instructions to hospitals for obtaining reimbursement for...

Powerful new method helps reveal genetic basis of cancer.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Researchers at Cold Spring Harbor Laboratory say they have developed one of the most sensitive, comprehensive, and robust methods that now exists for profiling the genetic basis of cancer and other...

Survivin is expressed in premalignant lesions, more in oral squamous cancers.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- The inhibitor of apoptosis, survivin, is expressed in many oral squamous cell cancers and fewer premalignant lesions, but not normal tissue. "A novel inhibitor of apoptosis, survivin, plays a role...

Combined surgical, chemotherapy approach gives disease control, high cure rates.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Combined surgical and chemotherapy approach provides excellent local disease control and high cure rates for high-grade maxillofacial osteosarcoma. "Maxillofacial osteosarcoma is a rare tumor....

Paclitaxel temporarily adds to the sensory neurotoxicity of cisplatin.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Paclitaxel temporarily adds to the sensory neurotoxicity of cisplatin. "Logically, the choice of any ultimate optimum therapy requires, as well as comparison of the survival outcomes, a comparison...

Tumors of the gonadal stroma are potentially malignant.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Tumors of the gonadal stroma are potentially malignant. "Most hormonally active ovarian tumors belong to the category of tumors of the gonadal stroma. These account for less than 5% of all ovarian...

Oncofetal protein p65 may be useful added marker in prostate cancer.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Oncofetal protein p65 was more common in sera of prostate cancer patients, but would not be able to be used as a marker alone. According to a study from the United States, "The concentration of a...

Pseudomyxoma peritonei is reviewed.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Pseudomyxoma peritonei, a controversial disease, is reviewed. According to recent research published in the International Journal of Gynecological Cancer, "Pseudomyxoma peritonei (PMP) is a rare...

Math tool promises to cut dose calculation time.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Researchers at Washington University in St. Louis have developed a technique that drastically decreases the time a radiologist spends calculating radiation dosages and also provides a more carefully...

Endosonograpy and MRI are important in staging rectal cancer.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Endosonograpy and MRI are important in staging rectal cancer. According to published research from Austria, "Rectal cancer is one of the most frequent neoplasias, with an incidence of 40 in 100...

A transplanted kidney can be interpreted as a malignant lesion on FDG PET.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- A transplanted kidney can be interpreted as a malignant lesion on FDG PET. "Renal transplantation has become an effective therapy for patients with late-stage renal disease," investigators in the...

Devices could help diagnose precursors to cancer.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- A Massachusetts Institute of Technology interdepartmental laboratory has received $7.2 million from the U.S. National Institutes of Health (NIH) to further its work on devices that can detect and image...

Two UN agencies and partners launch campaign to prevent overexposure to sun.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Two United Nations agencies and their partners have launched a set of new educational materials to help children around the world become more aware of the dangers from ultraviolet radiation (UV) from...

Cutaneous T-cell lymphoma patients do not show association with Chlamydia.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Mycosis fungoides, a cutaneous T cell lymphoma type, does not have Chlamydia pneumoniae DNA or antigens associated, as had been reported. According to published research from Germany, "Recently,...

Erythropoietin reduces transfusion needs during aggressive lymphoma treatment.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Erythropoietin can reduce transfusion needs and improve quality of life in patients undergoing aggressive treatment for lymphoma. Researchers in Germany conducted a study "to investigate the...

Granisetron effective as antiemitic for bone marrow transplant recipients.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Granisetron is effective as an antiemetic for bone marrow graft recipients. "Cancer patients undergoing bone marrow transplantation (BMT) experience severe nausea and vomiting associated with...

Many British oncologists unaware of cancer clot risk.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Patients receiving cancer treatments are at greater risk of blood clots, yet more than a quarter of oncologists do not recognize their clotting effects and preventive measures are rarely used, finds a...

Central line thrombosis in patients with cancer is a common complication.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Central line thrombosis in patients with cancer is a common complication. "Central venous catheters are used frequently to care for patients with cancer and often serve as long-term venous access,"...

Radioiodine improves prognosis for patients with pulmonary metastases.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Radioiodine improves prognosis for patients with thyroid cancer and pulmonary metastases. "Functioning pulmonary metastases are the most common distant lesions of differentiated thyroid cancer....

Tumor thickness predicts cervical nodal metastases and survival in early disease.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Tumor thickness predicts cervical nodal metastases and survival in early disease. "Squamous cell carcinoma (SCC) of the oral tongue is characterized by a high propensity for cervical nodal...

Noninvasive bladder cancer has microinvasion; may affect recurrence, progression.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- Many superficial, noninvasive types of human bladder cancer do have microinvasiveness in electron micrographs; examination of this potential may relate to recurrence and progression rates. ...

SPET and PET have a role in monitoring tumor response to therapy.
October 6, 2003... 2003 OCT 6 - (NewsRx.com & NewsRx.net) -- SPET and PET have a role in monitoring tumor response to therapy. According to published research from Greece, "Positron emission tomography (PET) and single-photon emission tomography (SPET) are...

First steps toward a vaccine described.
October 13, 2003... 2003 OCT 13 - (NewsRx.com & NewsRx.net) -- Research carried out in the United States has raised the hope that one day there could be a vaccine against pancreatic cancer - one of the most difficult cancers to treat successfully. Dr. Robert...

More children survive cancer but after-effects present challenges.
October 13, 2003... 2003 OCT 13 - (NewsRx.com & NewsRx.net) -- The number of children who survive childhood cancer is improving dramatically, but because of the side effects of their treatment, the majority continue to need specialist care for many years. ...

Antigen targeted in melanoma therapy also prompts response in brain tumor cells.
October 13, 2003... 2003 OCT 13 - (NewsRx.com & NewsRx.net) -- A protein fragment that was previously found in melanomas has now been detected in highly aggressive brain tumors called gliomas that take the lives of about 15,000 Americans each year. This...

Nordic collaboration gives new insights into adjuvant chemotherapy.
October 13, 2003... 2003 OCT 13 - (NewsRx.com & NewsRx.net) -- A major clinical collaboration by Scandinavian cancer specialists has shown that patients with advanced colon cancer could well gain a small but worthwhile improvement in 5-year overall survival if...

Anti-GD2 monoclonal antibody immunotherapy may prevent neuroblastoma relapse.
October 13, 2003... 2003 OCT 13 - (NewsRx.com & NewsRx.net) -- Anti-GD2 monoclonal antibody immunotherapy may prevent neuroblastoma relapse. "In spite of the satisfactory frequency of clinical response to first-line therapy in neuroblastoma (NB), complete...

Melphalan may be used for treatment of recurrent epithelial ovarian cancer.
October 13, 2003... 2003 OCT 13 - (NewsRx.com & NewsRx.net) -- Melphalan may be used for the treatment of patients with recurrent epithelial ovarian cancer. "The purpose of this study was to determine the response to melphalan in patients with recurrent...

Cisplatin, irinotecan, and epirubicin have promising broad antitumor activity.
October 13, 2003... 2003 OCT 13 - (NewsRx.com & NewsRx.net) -- Cisplatin, irinotecan, and epirubicin have promising broad antitumor activity. According to a study from Canada, "This phase I study was conducted to determine the recommended phase II doses,...

Primary hormone induced meningiomas may result from prostate cancer therapy.
October 13, 2003... 2003 OCT 13 - (NewsRx.com & NewsRx.net) -- Meningiomas are a risk in patients receiving hormone therapy as treatment for prostate cancer; meningioma may not be from metastasis, but primary, hormone induced cancer. "The relative...

Researchers discuss threshold values for hematuria in cases of bladder cancer.
October 13, 2003... 2003 OCT 13 - (NewsRx.com & NewsRx.net) -- Researchers discuss threshold values for hematuria in cases of bladder cancer. According to published research from Germany, "In the majority of cases, painless macroscopic hematuria is a typical...

Review of literature evaluates quality of life aspects of bladder cancer.
October 13, 2003... 2003 OCT 13 - (NewsRx.com & NewsRx.net) -- Review of literature evaluates the quality of life aspects of bladder cancer. According to recent research from the United States, "Not much is generally known regarding the burden imposed by...

Tl-201 pelvic SPELT scan could is useful in detecting bladder cancer.
October 13, 2003... 2003 OCT 13 - (NewsRx.com & NewsRx.net) -- Tl-201 pelvic SPELT scan could is useful in detecting bladder cancer. According to recent research from Taiwan, "Thallium-201 (Tl-201) is a recognized tumor-imaging agent; however, the usefulness...

After cryosurgery, no bone tumor recurrence or complications were detected.
October 13, 2003... 2003 OCT 13 - (NewsRx.com & NewsRx.net) -- After cryosurgery, no bone tumor recurrence or complications were detected. According to recent research published in the journal International Orthopaedics, "The objective of this study was to...

Metastatic pilocytic astrocytoma may be treatable with imatinib mesylate.
October 13, 2003... 2003 OCT 13 - (NewsRx.com & NewsRx.net) -- Pediatric pilocytic astrocytomas do not appear to express PDGFR in the tumor, nor any known target molecules of imatinib mesylate, yet treatment of a patient produced tumor regression. According...